Repligen Corp at Jefferies Healthcare Conference (Virtual) Transcript
All right. We'll go ahead and get started. Thanks, everyone, for joining us. Welcome to the Jefferies 2021 Global Healthcare Conference. I'm Brandon Couillard. I cover the Life Science Tools and Diagnostics sector here at the firm. It's my great pleasure to have Repligen with us back at the conference this year. Joining us for this conversation this afternoon, CEO, Tony Hunt; CFO, Jon Snodgres. Gentlemen, thanks for being here.
Thanks, Brandon.
Questions & Answers
Tony, to jump in and kick-off. I think one of the certainly biggest debates and conversations among investors right now is just kind of what does the vaccine-related revenue picture look like second half of this year, but also into '22? Just near term, you did $35 million in the first quarter, kind of pointed to about $150 million at the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
